Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Mar-24
- 18-Apr-24
- 02-May-24
Select bar for recommendation details.
Recommendations | 02-May-24 | |
---|---|---|
Buy | 0 | |
Outperform | 0 | |
Hold | 1 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast
The 2 analysts offering 12 month price targets for Shield Therapeutics PLC have a median target of 26.00, with a high estimate of 50.00 and a low estimate of 2.00. The median estimate represents a 1,577.42% increase from the last price of 1.55.
High | 3,125.8% | 50.00 |
Med | 1,577.4% | 26.00 |
Low | 29.0% | 2.00 |
Earnings history & estimates
Average growth rate | -149.81% |
More ▼
Revenue history & estimates
Average growth rate | +339.85% |
More ▼